Novo Nordisk announced on Wednesday that it is trimming its full-year profit outlook following weaker-than-expected quarterly sales of its popular weight-loss drug,
Novo Nordisk announced on Wednesday that it is trimming its full-year profit outlook following weaker-than-expected quarterly sales of its popular weight-loss drug,